dilazep has been researched along with trequinsin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Balzarini, J; Borst, P; De Haas, M; Reid, G; Van Deemter, L; Wielinga, P; Wijnholds, J; Zelcer, N | 1 |
| Agarwal, KC; Buckley, RS; Parks, RE | 1 |
3 other study(ies) available for dilazep and trequinsin
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5.
Topics: Acrylates; Biological Transport; Cell Division; Cells, Cultured; Humans; Multidrug Resistance-Associated Proteins; Nucleosides; Polymers | 2003 |
Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Animals; Blood Platelets; Dilazep; Dipyridamole; Drug Synergism; Humans; Isoquinolines; Male; Mopidamol; Platelet Aggregation; Pyrimidines; Rats; Rats, Inbred Strains; Species Specificity; Tetrahydroisoquinolines | 1987 |